Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Is trospium chloride an effective and safe treatment for overactive bladder syndrome?

Nature Clinical Practice Urology volume 1, pages 22–23 (2004)Cite this article

boxed-textZinner N et al. for the Trospium Study Group (2004) Trospium chloride improves overactive bladder symptoms: a multicenter Phase III trial. J Urol 171: 2311–2315

Trospium chloride seems to be similar to other antimuscarinic agents used in the treatment of OAB; direct comparative studies are needed to determine its ultimate utility

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Herbison P et al. (2003) Effectiveness of anticholinergic drugs compared with placebo in the treatment of overactive bladder: systematic review. BMJ 326: 841–844

    Article  CAS  Google Scholar 

  2. Pietzko A et al. (1994) Influences of trospium chloride and oxybutynin on quantitative EEG in healthy volunteers. Eur J Clin Pharmacol 47: 337–343

    Article  CAS  Google Scholar 

  3. Todorova A et al. (2001) Effects of tolterodine, trospium chloride, and oxybutynin on the central nervous system. J Clin Pharmacol 41: 636–644

    Article  CAS  Google Scholar 

  4. Herberg K-W (1999) General and traffic safety and the effects of incontinence medication: new studies on the safety potential of urological anticholinergics. Die Medizinische Welt 50: 217

    Google Scholar 

  5. Jünemann KP and Al-Shukri S : Efficacy and tolerability of trospium chloride and tolterodine in 234 patients with urge-syndrome: a double-blind, placebo-controlled, multicentre clinical trial. In Proceedings of the Annual Meeting of the International Continence Society: 2000 August 28; Tampere

Download references

Acknowledgements

The synopsis was written by Suzanne Farley, Associate Editor, Nature Clinical Practice.

Author information

Authors and Affiliations

  1. Associate Professor of Urology, and Director of the Section of Female Urology and Neurourology, Stanford University School of Medicine,

    Christopher K Payne

Authors
  1. Christopher K Payne
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Christopher K Payne.

Ethics declarations

Competing interests

Dr Payne is a consultant for Yamanouchi Corporation, Schwarz Pharma, Pfizer, American Medical Systems, and Roche Pharmaceuticals, and an investigator for BION and Q-Med Corporation.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Payne, C. Is trospium chloride an effective and safe treatment for overactive bladder syndrome?. Nat Rev Urol 1, 22–23 (2004). https://doi.org/10.1038/ncpuro0011

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpuro0011

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing